Jennifer Drevin studies the donation of human embryonic stem cells for development of advanced therapeutic medical products. Her research is a subproject within the SweLife ATMP project, funded by Vinnova. Jennifer Drevin studies the values and preferences of donors, patients, the general public, and policy makers in relation to donation of human embryonic stem cells for development of therapeutic treatments. She uses preference studies to understand how stakeholders balance their different interests and values. Jennifer Drevin is also part of the Innovative Medicines Initiative (IMI) funded ConcePTION project.
Jennifer Drevin is a registered nurse, holds a Master’s degree in Public Health and a Doctoral degree in Medicine from Uppsala University. In her PhD project she conducted epidemiological and psychometric studies within the field of Reproductive Health.
Phone: +46 18 471 62 88
Perceptions on using surplus embryos for the treatment of Parkinson’s disease among the Swedish population: a qualitative study
Part of BMC Medical Ethics, 2022.
Part of Läkartidningen, 2020.
Childhood abuse and unplanned pregnancies: a cross-sectional study of women in the Norwegian Mother and Child Cohort Study
Part of British Journal of Obstetrics and Gynecology, p. 438-446, 2020.
Measuring Pregnancy Planning and the Effect of Childhood Abuse on Reproductive Health
Part of Journal of Advanced Nursing, p. 2765-2775, 2017.
Exploring men's pregnancy-planning behaviour and fertility knowledge: a survey among fathers in Sweden
Part of Upsala Journal of Medical Sciences, p. 127-135, 2017.
Part of Acta Obstetricia et Gynecologica Scandinavica, p. 840-846, 2015.